Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia
Article in British Journal of Haematology (April 2024)
The most recent citing publications are shown below. View all 281 publications that cite this research output on Dimensions.
Article in British Journal of Haematology (April 2024)
Preprint in bioRxiv (April 2024)
Article in Pharmacology & Therapeutics (February 2024)